Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Jiangsu Jibeier Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.07 Million ≈ $1.62 Million USD) by net assets (CN¥2.37 Billion ≈ $346.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688566 share price today for real-time trading data and today's change.
Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Jiangsu Jibeier Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 688566 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tortoise Energy Infrastructure Closed Fund
NYSE:TYG
|
0.017x |
|
Salfacorp
SN:SALFACORP
|
0.122x |
|
Shandong Link Science and Technology Co Ltd
SHE:001207
|
0.031x |
|
Ridgepost Capital, Inc
NYSE:RPC
|
0.042x |
|
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
IS:ECILC
|
0.014x |
|
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658
|
0.054x |
|
Hangzhou Jiebai Group Co Ltd
SHG:600814
|
0.048x |
|
Hiecise Precision Equipment Co Ltd
SHE:300809
|
0.040x |
Annual Cash Flow Conversion Efficiency for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. Review Jiangsu Jibeier Pharmaceutical Co Ltd (688566) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.45 Billion ≈ $358.46 Million |
CN¥248.30 Million ≈ $36.33 Million |
0.101x | +6.11% |
| 2024-12-31 | CN¥2.25 Billion ≈ $329.81 Million |
CN¥215.29 Million ≈ $31.50 Million |
0.096x | +14.41% |
| 2023-12-31 | CN¥1.91 Billion ≈ $279.55 Million |
CN¥159.50 Million ≈ $23.34 Million |
0.083x | -6.15% |
| 2022-12-31 | CN¥1.69 Billion ≈ $247.93 Million |
CN¥150.72 Million ≈ $22.06 Million |
0.089x | -4.97% |
| 2021-12-31 | CN¥1.61 Billion ≈ $235.34 Million |
CN¥150.56 Million ≈ $22.03 Million |
0.094x | +25.73% |
| 2020-12-31 | CN¥1.58 Billion ≈ $230.67 Million |
CN¥117.36 Million ≈ $17.17 Million |
0.074x | -69.66% |
| 2019-12-31 | CN¥470.46 Million ≈ $68.84 Million |
CN¥115.45 Million ≈ $16.89 Million |
0.245x | -10.41% |
| 2018-12-31 | CN¥357.68 Million ≈ $52.34 Million |
CN¥97.97 Million ≈ $14.34 Million |
0.274x | +8.12% |
| 2017-12-31 | CN¥440.76 Million ≈ $64.50 Million |
CN¥111.66 Million ≈ $16.34 Million |
0.253x | +134.16% |
| 2016-12-31 | CN¥363.15 Million ≈ $53.14 Million |
CN¥39.29 Million ≈ $5.75 Million |
0.108x | -- |
About Jiangsu Jibeier Pharmaceutical Co Ltd
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing… Read more